Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. (Q48187678)

9 February 2018

title

Assessment of cognitive brain function in ecstasy users and contributions of other drugs of abuse: results from an FMRI study. (English)

1 reference

9 February 2018

Nick F Ramsey

8

0 references

René S. Kahn

5

Rene S Kahn

1 reference

9 February 2018

Ingeborg van der Tweel

3

Ingeborg van der Tweel

1 reference

9 February 2018

Gerry Jager

1

Gerry Jager

1 reference

9 February 2018

Maartje M L de Win

2

Maartje M L de Win

1 reference

9 February 2018

Thelma Schilt

4

Thelma Schilt

1 reference

9 February 2018

author name string

Wim van den Brink

6

1 reference

9 February 2018

Jan M van Ree

7

1 reference

9 February 2018

language of work or name

English

0 references

publication date

25 April 2007

1 reference

9 February 2018

published in

Neuropsychopharmacology

1 reference

9 February 2018

volume

33

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

247-258

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301415

exact match

0 references

cites work

Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Imaging brain activity in conscious monkeys following oral MDMA ("ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Functional MRI studies of spatial and nonspatial working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Long-term effects of frequent cannabis use on working memory and attention: an fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Effects of frequent cannabis use on hippocampal activity during an associative memory task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Functional anatomical correlates of controlled and automatic processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Functional MRI study of working memory in MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Ecstasy: pharmacology and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Neurophysiological factors in human information processing capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Functional mapping of human sensorimotor cortex with 3D BOLD fMRI correlates highly with H2(15)O PET rCBF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Phase navigator correction in 3D fMRI improves detection of brain activation: quantitative assessment with a graded motor activation procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Neural correlates of cognitive efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

'Is MDMA a human neurotoxin?': diverse views from the discussants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

An fMRI study of the effect of amphetamine on brain activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Specific memory deficits in ecstasy users? The results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Analysis of fMRI time-series revisited--again.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

inferred from DOI database lookup

7 January 2021

based on heuristic

Human hippocampus establishes associations in memory.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

inferred from DOI database lookup

7 January 2021

based on heuristic

Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301415

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.NPP.1301415

1 reference

9 February 2018

PubMed ID

17460617

1 reference

9 February 2018